Uroflowmetry Curve Types and IPSS in Men With LUTS
Launched by TARIK EMRE SENER · Jun 8, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different patterns of urine flow, measured through a test called uroflowmetry, relate to the symptoms men experience with lower urinary tract issues, like trouble urinating or frequent urges, known collectively as lower urinary tract symptoms (LUTS). The researchers want to see how these flow patterns connect with survey results from a questionnaire called the International Prostate Symptom Score (IPSS), which helps assess the severity of urinary symptoms. By understanding these correlations, the study aims to improve clinical decisions for treating men with these conditions.
To join this study, participants need to be male, at least 40 years old, and experiencing LUTS. They should be able to complete the IPSS questionnaire and have had certain tests, including a urine flow test and blood work. However, men who have had prostate surgery, have a urinary tract infection, or use a urinary catheter cannot participate. If eligible, participants can expect to undergo standard medical evaluations and answer questions about their symptoms to help researchers gather valuable information for better treatment options.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- * Inclusion Criteria:
- • Male patients aged 40 years or older
- • Presenting with lower urinary tract symptoms (LUTS)
- • Able to complete the IPSS questionnaire
- • Underwent uroflowmetry and serum creatinine testing
- Exclusion Criteria:
- • History of prior prostate surgery
- • Active urinary tract infection
- • Known diagnosis of neurogenic bladder
- • Current use of indwelling urinary catheter
About Tarik Emre Sener
Tarik Emre Sener is a dedicated clinical trial sponsor with a commitment to advancing medical research and improving patient outcomes. With a strong focus on innovative therapies and evidence-based practices, Sener leads initiatives that explore novel treatment options across various therapeutic areas. His expertise in clinical development, regulatory compliance, and strategic planning enables the successful execution of trials that adhere to the highest ethical and scientific standards. Through collaboration with healthcare professionals and research institutions, Tarik Emre Sener aims to bridge the gap between research and real-world application, ultimately contributing to the betterment of global health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported